The MaxDiscovery™ Human IL-13 ELISA Test Kit is designed for quantitative determination of the concentration of human IL-13 in serum, plasma, and cell culture supernatant. Human interleukin 13 (IL-13) is a protein of 112 amino acids after cleavage of a 20 amino acid signal peptide. It is polymorphic with isoforms containing either Gly or Asp at position 61 and a Gln insertion at position 98. At the amino acid sequence level, mature human IL-13 is approximately 58% identical to mouse IL-13. It shows approximately 30% amino acid sequence identity with IL-4 and shares many biological properties with IL-4. IL-13 is produced primarily by activated T lymphocytes and has multiple effects on the differentiation and functions of monocytes/macrophages. It can suppress the cytotoxic functions of monocytes/macrophages and the production of proinflammatory cytokines by monocytes/macrophages. Although human or mouse IL-13 has effects similar to those of IL-4 on human B cells, mouse IL-13 has no effect on mouse B cells. Unlike IL-4, which is a growth and differentiation factor for human and mouse T cells, IL-13 has no effects on either human or mouse T cells. While human and mouse IL-13 are equally active on human cells, human IL-13 is much less active than the mouse protein on mouse cells. The gene for IL-13 has been mapped to human chromosome 5q31, in close proximity to the genes for IL-3, IL-4, IL-5 and GM-CSF. The biological effects of IL-13 are mediated by specific high-affinity cell surface receptor complexes. The functional IL-13 receptor complex has been shown to consist of the low-affinity IL-13 receptor a chain and the IL-4 receptor a subunit (IL-4 Ra). This IL-13 receptor complex may also serve as an alternate high-affinity IL-4 receptor complex in IL-4 responsive cells that lack the ?c chain.
Charting Kidney Cancer Metabolism Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.Insights into the Function of the Main Class of Drug Targets About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.Visualizing a Cancer Drug Target at Atomic Resolution Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.Honey’s Potential to Save Lives The healing powers of honey have been known for thousands of years. 3-D Printed Lifelike Liver Tissue for Drug Screening A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling. Cytoskeleton Crew Findings confirm sugar's role in helping cancers survive by changing cellular architecture.Biomarker for Recurring HPV-Linked Oropharyngeal Cancers A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University. Valvena, GSK Sign New R&D Collaboration Valneva to supply process development services for EB66® -based Influenza vaccines. Light Signals from Living Cells Fluorescent protein markers delivered under high pressure.Cellular 'Relief Valve' A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.